Oruka Therapeutics, Inc.

Direct answer

Oruka Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ORKA.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in...

Can you invest in Oruka Therapeutics, Inc.?

Yes. Oruka Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ORKA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Oruka Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.